Ratings Remedy Entertainment Oyj

Equities

REMEDY

FI4000251897

Delayed Nasdaq Helsinki Other stock markets 11:29:52 2024-04-30 am EDT			5-day change	1st Jan Change
19.1 ^EUR	-0.52%		+14.10%	-24.80%

Apr. 29	Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024
Apr. 25	Remedy Entertainment Chief Operations Officer Plans May-end Exit	MT

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The company is in a robust financial situation considering its net cash and margin position.
Analyst opinion has improved significantly over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company has insufficient levels of profitability.
With an enterprise value anticipated at 4.61 times the sales for the current fiscal year, the company turns out to be overvalued.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
REMEDY ENTERTAINMENT OYJ	-24.80%	277M	-
MICROSOFT CORPORATION	+3.53%	2,894B	C+
SYNOPSYS INC.	+3.05%	80.94B	B
CADENCE DESIGN SYSTEMS, INC.	+1.20%	75.01B	B+
DASSAULT SYSTÈMES SE	-16.29%	52.08B	B+
PALANTIR TECHNOLOGIES INC.	+27.96%	48.93B	D+
ATLASSIAN CORPORATION	-27.56%	44.85B	B-
THE TRADE DESK, INC.	+15.13%	40.49B	D+
SEA LIMITED	+56.02%	36.29B	D+
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-11.27%	24.36B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes